X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-26 | XAIR | Carey Robert | Dir | P - Purchase | $0.50 | +1,476,626 | 1,476,626 | New | +$744,662 | |||||
| D | 2024-09-26 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $0.50 | +1,476,626 | 3,249,411 | +83% | +$744,662 | |||||
2024-08-15 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $0.37 | +50,000 | 1,772,785 | +3% | +$18,340 | ||||||
2024-08-14 | XAIR | Lucera Erick | Dir | P - Purchase | $0.40 | +39,266 | 43,608 | +904% | +$15,565 | ||||||
2024-08-14 | XAIR | Carey Robert | Dir | P - Purchase | $0.40 | +100,000 | 3,076,864 | +3% | +$39,680 | ||||||
2024-08-14 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $0.39 | +100,000 | 1,722,785 | +6% | +$38,640 | ||||||
2023-12-28 | XAIR | Avniel Amir | Chief Business Officer | S - Sale | $2.06 | -25,000 | 685,760 | -4% | -$51,451 | ||||||
2023-12-27 | XAIR | Myers Jeff Lynn | Chief Medical Officer | S - Sale | $2.21 | -3,423 | 46,577 | -7% | -$7,579 | ||||||
2023-12-18 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $1.63 | +77,775 | 1,536,471 | +5% | +$126,797 | ||||||
2023-12-18 | XAIR | Carey Robert | Dir | P - Purchase | $1.64 | +1,200,000 | 2,374,454 | +102% | +$1,962,000 | ||||||
2023-11-16 | XAIR | Gaul Michael A. | COO | P - Purchase | $1.77 | +10,000 | 88,150 | +13% | +$17,700 | ||||||
2023-08-28 | XAIR | Carey Robert | Dir | P - Purchase | $2.70 | +250,000 | 1,225,160 | +26% | +$673,750 | ||||||
| M | 2023-08-18 | XAIR | Carey Robert | Dir | P - Purchase | $2.75 | +88,664 | 975,160 | +10% | +$243,393 | |||||
2023-06-30 | XAIR | Gaul Michael A. | COO | P - Purchase | $4.51 | +5,000 | 78,150 | +7% | +$22,550 | ||||||
2023-03-31 | XAIR | Forbes William P | Dir | P - Purchase | $6.67 | +5,000 | 14,855 | +51% | +$33,350 | ||||||
| M | 2023-03-29 | XAIR | Carey Robert | Dir | P - Purchase | $6.38 | +20,000 | 886,496 | +2% | +$127,500 | |||||
2023-03-28 | XAIR | Lee Yoori | Dir | P - Purchase | $6.34 | +3,115 | 12,654 | +33% | +$19,749 | ||||||
2023-03-24 | XAIR | Gaul Michael A. | COO | P - Purchase | $6.15 | +1,000 | 73,150 | +1% | +$6,150 | ||||||
2023-03-17 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $6.46 | +10,000 | 1,458,696 | +1% | +$64,600 | ||||||
2023-03-20 | XAIR | Bentsur Ron | Dir | P - Purchase | $6.48 | +2,300 | 144,736 | +2% | +$14,904 | ||||||
2023-03-16 | XAIR | Lucera Erick | Dir | P - Purchase | $6.82 | +2,000 | 4,342 | +85% | +$13,634 | ||||||
2023-03-17 | XAIR | Forbes William P | Dir | P - Purchase | $6.46 | +5,000 | 9,855 | +103% | +$32,300 | ||||||
2023-03-13 | XAIR | Avniel Amir | Chief Business Officer | P - Purchase | $6.40 | +1,000 | 457,027 | 0% | +$6,400 | ||||||
| M | 2023-03-13 | XAIR | Carey Robert | Dir | P - Purchase | $6.64 | +14,173 | 866,496 | +2% | +$94,164 | |||||
2023-03-07 | XAIR | Gaul Michael A. | COO | P - Purchase | $5.86 | +8,000 | 72,150 | +12% | +$46,880 | ||||||
| M | 2023-03-07 | XAIR | Lisi Steven A. | CEO, COB | P - Purchase | $5.97 | +50,000 | 1,447,849 | +4% | +$298,355 | |||||
2023-03-08 | XAIR | Carey Robert | Dir | P - Purchase | $5.95 | +10,000 | 852,323 | +1% | +$59,500 | ||||||
2023-02-16 | XAIR | Lisi Steven A. | CEO, COB | S - Sale | $6.10 | -48,596 | 1,397,849 | -3% | -$296,436 | ||||||
2022-12-07 | XAIR | Carey Robert | Dir | P - Purchase | $5.75 | +20,000 | 842,323 | +2% | +$115,000 | ||||||
| M | 2022-11-28 | XAIR | Carey Robert | Dir | P - Purchase | $5.75 | +30,000 | 822,323 | +4% | +$172,491 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |